203 related articles for article (PubMed ID: 11698760)
1. Epstein-Barr virus and posttransplant lymphoproliferative disease.
Holmes R
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):442-4. PubMed ID: 11698760
[No Abstract] [Full Text] [Related]
2. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
Kogan-Liberman D; Burroughs M; Emre S; Moscona A; Shneider BL
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
Petrovic LM
Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
[No Abstract] [Full Text] [Related]
4. Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative disease.
Lucas KG; Filo F; Heilman DK; Lee CH; Emanuel DJ
Blood; 1998 Nov; 92(10):3977-8. PubMed ID: 9867357
[No Abstract] [Full Text] [Related]
5. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences?
Green M; Webber SA
Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870
[No Abstract] [Full Text] [Related]
6. [Clinical significance of Epstein-Barr virus load].
Dehée A
Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():28-33. PubMed ID: 11675291
[No Abstract] [Full Text] [Related]
7. Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease.
Allen U; Hebert D; Petric M; Tellier R; Tran D; Superina R; Stephens D; West L; Wasfy S; Nelson S
Clin Infect Dis; 2001 Jul; 33(2):145-50. PubMed ID: 11418872
[TBL] [Abstract][Full Text] [Related]
8. Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.
Haque T; Crawford DH
Springer Semin Immunopathol; 1998; 20(3-4):375-87. PubMed ID: 9870252
[No Abstract] [Full Text] [Related]
9. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.
Glotz D; Chapman JR; Dharnidharka VR; Hanto DW; Castro MC; Hirsch HH; Leblond V; Mehta AK; Moulin B; Pagliuca A; Pascual J; Rickinson AB; Russo FP; Trappe RU; Webster AC; Zuckermann AO; Gross TG
Transplantation; 2012 Oct; 94(8):784-93. PubMed ID: 22992767
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant lymphoproliferative diseases.
Gross TG; Savoldo B; Punnett A
Pediatr Clin North Am; 2010 Apr; 57(2):481-503, table of contents. PubMed ID: 20371048
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
[No Abstract] [Full Text] [Related]
12. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
Paya CV; Fung JJ; Nalesnik MA; Kieff E; Green M; Gores G; Habermann TM; Wiesner PH; Swinnen JL; Woodle ES; Bromberg JS
Transplantation; 1999 Nov; 68(10):1517-25. PubMed ID: 10589949
[TBL] [Abstract][Full Text] [Related]
13. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.
Smets F; Latinne D; Bazin H; Reding R; Otte JB; Buts JP; Sokal EM
Transplantation; 2002 May; 73(10):1603-10. PubMed ID: 12042647
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
[TBL] [Abstract][Full Text] [Related]
15. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
Kumar D; Patil N; Husain S; Chaparro C; Bhat M; Kim SJ; Humar A
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489256
[TBL] [Abstract][Full Text] [Related]
16. Donor or recipient origin of posttransplantation lymphoproliferative disorders: the traces of the Epstein-Barr virus.
Volk HD; Babel N; Reinke P
Transplantation; 2001 Aug; 72(3):361-2. PubMed ID: 11502960
[No Abstract] [Full Text] [Related]
17. Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update.
Dierickx D; Tousseyn T; De Wolf-Peeters C; Pirenne J; Verhoef G
Leuk Lymphoma; 2011 Jun; 52(6):950-61. PubMed ID: 21338285
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr viral load before a liver transplant in children with chronic liver disease.
Shakibazad N; Honar N; Dehghani SM; Alborzi A
Exp Clin Transplant; 2014 Dec; 12(6):534-8. PubMed ID: 25489804
[TBL] [Abstract][Full Text] [Related]
19. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction.
Wagner HJ; Wessel M; Jabs W; Smets F; Fischer L; Offner G; Bucsky P
Transplantation; 2001 Sep; 72(6):1012-9. PubMed ID: 11579293
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders.
Gross TG
J Pediatr Hematol Oncol; 2001 Jan; 23(1):7-9. PubMed ID: 11196278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
